LIPO-HEPIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lipo-hepin, and when can generic versions of Lipo-hepin launch?
Lipo-hepin is a drug marketed by 3M and is included in one NDA.
The generic ingredient in LIPO-HEPIN is heparin sodium. There are seventy-seven drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lipo-hepin
A generic version of LIPO-HEPIN was approved as heparin sodium by HOSPIRA on April 28th, 1983.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LIPO-HEPIN?
- What are the global sales for LIPO-HEPIN?
- What is Average Wholesale Price for LIPO-HEPIN?
Summary for LIPO-HEPIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Patent Applications: | 3,164 |
| DailyMed Link: | LIPO-HEPIN at DailyMed |
US Patents and Regulatory Information for LIPO-HEPIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
